Join our daily newsletter At The Bell to receive exclusive market insights
- PainChek (PCK) is rolling out its pain assessment solution through retirement village and aged care service provider Summerset, following a successful six-month trial
- This 12 month contract is the first rollout of PainChek in New Zealand
- Under the agreement, the solution will be rolled out across all of Summerset’s 24 care centres, totalling 1150 beds
- The roll-out of PainChek to Summerset is expected to be carried out over 2022, and the company is confident that a full roll-out can also be deployed remotely by its Australia-based team
- PCK shares are up 5.13 per cent, trading at 4.1 cents per share
PainChek (PCK) is rolling out its pain assessment solution through retirement village and aged care service provider Summerset, following a successful six-month trial.
The contract is the first rollout of PainChek in New Zealand which began at Summerset’s Levin site in early August 2021, and it is said that this arrangement is materially significant in the international expansion of the PainChek business.
In the six months, the device was able to demonstrate that it could remotely assist care centre personnel in responding more quickly to patients who were in pain but
may not be able verbalise it.
The company has now formed an initial 12-month agreement with Summerset to roll out the pain management solution across all of Summerset’s 24 care centres, totalling 1150 beds.
Head of Clinical Services at Summerset Lynda Irvine believes the greatest benefit of PainChek is that it allows care staff to accurately assess and manage pain for all residents and those who often don’t have a voice when it comes to expressing their pain.
“PainChek really made us think about how important effective pain management is for older people and a key advantage is being able to rule out pain as a contributing factor for residents who are at times distressed,” she said.
“The connection with VCare reduces duplication for clinical staff and means the team can spend a little more time each day with residents.”
So far, the company has said it has “seamlessly and remotely managed” the engagement with Summerset, from sales through to implementation to support.
The roll-out of PainChek to Summerset is expected to be carried out over 2022, and the company is confident that a full roll-out can also be deployed remotely by its Australia-based team.
PCK shares were up 5.13 per cent, trading at 4.1 cents per share as of 1:40 pm AEDT.
